3-4675201-C-T

Variant summary

Our verdict is Likely benign. Variant got -2 ACMG points: 1P and 3B. PP2BP4_ModerateBP6

The NM_001378452.1(ITPR1):​c.2732C>T​(p.Ala911Val) variant causes a missense change. The variant allele was found at a frequency of 0.000323 in 1,611,800 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. A911A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00041 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00031 ( 0 hom. )

Consequence

ITPR1
NM_001378452.1 missense

Scores

6
13

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:2

Conservation

PhyloP100: 4.45
Variant links:
Genes affected
ITPR1 (HGNC:6180): (inositol 1,4,5-trisphosphate receptor type 1) This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene. [provided by RefSeq, Nov 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -2 ACMG points.

PP2
Missense variant in gene, where missense usually causes diseases (based on misZ statistic), ITPR1. . Gene score misZ 5.5951 (greater than the threshold 3.09). Trascript score misZ 6.2026 (greater than threshold 3.09). GenCC has associacion of gene with spinocerebellar ataxia type 15/16, aniridia-cerebellar ataxia-intellectual disability syndrome, spinocerebellar ataxia type 29.
BP4
Computational evidence support a benign effect (MetaRNN=0.07862571).
BP6
Variant 3-4675201-C-T is Benign according to our data. Variant chr3-4675201-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 345716.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=4, Likely_benign=2}.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ITPR1NM_001378452.1 linkuse as main transcriptc.2732C>T p.Ala911Val missense_variant 23/62 ENST00000649015.2
ITPR1NM_001168272.2 linkuse as main transcriptc.2687C>T p.Ala896Val missense_variant 22/61
ITPR1NM_001099952.4 linkuse as main transcriptc.2732C>T p.Ala911Val missense_variant 23/59
ITPR1NM_002222.7 linkuse as main transcriptc.2687C>T p.Ala896Val missense_variant 22/58

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ITPR1ENST00000649015.2 linkuse as main transcriptc.2732C>T p.Ala911Val missense_variant 23/62 NM_001378452.1 Q14643-1

Frequencies

GnomAD3 genomes
AF:
0.000408
AC:
62
AN:
152070
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000966
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000393
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000189
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000720
Gnomad OTH
AF:
0.000479
GnomAD3 exomes
AF:
0.000368
AC:
91
AN:
247512
Hom.:
0
AF XY:
0.000380
AC XY:
51
AN XY:
134292
show subpopulations
Gnomad AFR exome
AF:
0.000130
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.000299
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000372
Gnomad NFE exome
AF:
0.000675
Gnomad OTH exome
AF:
0.000334
GnomAD4 exome
AF:
0.000314
AC:
459
AN:
1459730
Hom.:
0
Cov.:
30
AF XY:
0.000340
AC XY:
247
AN XY:
726088
show subpopulations
Gnomad4 AFR exome
AF:
0.0000599
Gnomad4 AMR exome
AF:
0.0000450
Gnomad4 ASJ exome
AF:
0.000536
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000233
Gnomad4 FIN exome
AF:
0.000337
Gnomad4 NFE exome
AF:
0.000363
Gnomad4 OTH exome
AF:
0.000249
GnomAD4 genome
AF:
0.000408
AC:
62
AN:
152070
Hom.:
0
Cov.:
32
AF XY:
0.000377
AC XY:
28
AN XY:
74264
show subpopulations
Gnomad4 AFR
AF:
0.0000966
Gnomad4 AMR
AF:
0.000393
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.000189
Gnomad4 NFE
AF:
0.000720
Gnomad4 OTH
AF:
0.000479
Alfa
AF:
0.000529
Hom.:
0
Bravo
AF:
0.000351
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.000257
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000314
AC:
38
EpiCase
AF:
0.000491
EpiControl
AF:
0.000416

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:4Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:3
Uncertain significance, criteria provided, single submitterclinical testingGeneDxOct 26, 2022In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 29925855, 29232918, 30778698) -
Uncertain significance, criteria provided, single submitterclinical testingInvitaeJan 09, 2024This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 896 of the ITPR1 protein (p.Ala896Val). This variant is present in population databases (rs201519806, gnomAD 0.06%). This missense change has been observed in individual(s) with hereditary spastic pariplegia (PMID: 30778698). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 345716). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ITPR1 protein function with a negative predictive value of 95%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Uncertain significance, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJan 01, 2023- -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJun 02, 2023The c.2687C>T (p.A896V) alteration is located in exon 22 (coding exon 20) of the ITPR1 gene. This alteration results from a C to T substitution at nucleotide position 2687, causing the alanine (A) at amino acid position 896 to be replaced by a valine (V). This variant is unlikely to be causative of spinocerebellar ataxia; however, its contribution to the development of Gillespie syndrome is uncertain. Based on data from the Genome Aggregation Database (gnomAD) database, the ITPR1 c.2687C>T alteration was observed in 0.04% (103/278904) of total alleles studied, with a frequency of 0.07% (86/127962) in the European (non-Finnish) subpopulation. This variant was identified in two families with hereditary spastic paraplegia (Elert-Dobkowska, 2019). This amino acid position is not well conserved in available vertebrate species. The p.A896V alteration is predicted to be tolerated by in silico analysis. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Spinocerebellar ataxia type 29 Benign:1
Likely benign, criteria provided, single submitterresearchSchule lab, Hertie Institute for Clinical Brain ResearchFeb 09, 2018- -
Autosomal dominant cerebellar ataxia Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.35
T
BayesDel_noAF
Benign
-0.38
CADD
Uncertain
24
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.49
.;.;.;.;.;.;T;.;.;.
Eigen
Benign
-0.18
Eigen_PC
Benign
-0.10
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.88
D;D;D;D;D;D;D;D;.;D
M_CAP
Benign
0.028
D
MetaRNN
Benign
0.079
T;T;T;T;T;T;T;T;T;T
MetaSVM
Uncertain
-0.22
T
MutationAssessor
Benign
0.14
N;.;.;.;.;.;N;.;.;.
MutationTaster
Benign
0.83
D;D;D;D;N;N;N
PrimateAI
Uncertain
0.60
T
PROVEAN
Benign
-1.5
N;N;N;N;.;.;.;.;N;.
REVEL
Benign
0.21
Sift
Benign
0.44
T;T;T;T;.;.;.;.;T;.
Sift4G
Benign
0.37
T;T;.;T;.;.;.;.;T;.
Polyphen
0.69
.;.;.;.;.;.;P;.;.;.
Vest4
0.27
MVP
0.54
MPC
0.76
ClinPred
0.029
T
GERP RS
3.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.054
gMVP
0.54

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.060
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs201519806; hg19: chr3-4716885; COSMIC: COSV56986903; COSMIC: COSV56986903; API